申请人:Best John Desmond
                            
                            
                                公开号:US20050288376A1
                            
                            
                                公开(公告)日:2005-12-29
                            
                            Compounds of formula (I):
R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and
R
1
is bicyclyl or heterobicyclyl, are useful in the treatment and prophylaxis of conditions mediated by s-CD23.
                            式(I)的化合物:
其中R为氢、烷基、烯基、炔基、芳基、杂芳基或杂环基;
R1为双环或杂双环基,
可用于治疗和预防由s-CD23介导的疾病。